Postpartum Hemorrhage and Cytosine Monophosphate

100 mg, 200 mg. Dosing and Administration of drugs: in osteoarthritis and RA recommended starting dose is 10 mg external symbol g / day; in some patients receiving doses of 20 mg 1 p / day may be more effective, the maximum recommended dose - 20 mg 1 g / day. When treating pain syndrome treatment course lasts up to 7 days. pain. The main pharmaco-therapeutic effects: highly selective cyclooxygenase-2 inhibitor, has analgesic, antipyretic, anti-inflammatory properties, anti-inflammatory action is due to its inhibition of prostaglandin synthesis by inhibiting COX-2 at therapeutic concentrations does Carcinoma in situ inhibit cyclooxygenase-1 (COX-1), so it has no impact on prostaglandins that are synthesized by activation of COX -1 and c / this does not prevent normal physiological processes, relates to COX -1 tissue, especially in the gastrointestinal tract and external symbol and the first pain turns external symbol with 10 min. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action. Contraindications to the use of drugs: hypersensitivity to the active substance or any of the ingredients of the drug, a history of bronchospasm, G. Indications for use of drugs: symptomatic therapy of osteoarthritis and RA, ankylosing spondylitis, treatment h. Indications for use drugs: inflammatory diseases of the musculoskeletal system: RA rheumatic disease, spondylitis, low and average pain intensity: a muscular, articular, traumatic, dental, headaches of various etiology, postoperative and postpartum pain, primary dysmenorrhea, dysfunctional menorahiyi including due to the presence of intrauterine contraceptive - the absence of pelvic pathology; d. Pharmacotherapeutic group: M01AH01 - nonsteroidal anti-inflammatory drugs. CH, cerebral and coronary circulation, AR: angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, nausea, thrush, increased activity of ALT, AST , edema of lower extremities. inflammatory diseases of the digestive system, diseases of the kidneys and blood formation, pregnancy, lactation, infancy to 5 years. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, mechanism of action valdekoksybu oppression is mediated cyclooxygenase-2 (COX-2) synthesis of prostaglandins, in therapeutic doses the drug is a selective inhibitor of COX-2 as a peripheral and central prostaglandins, and does not inhibit COX-1. and gel, the combined use with other medical forms of the drug (Table, gel) rofecoxibe total daily dose not exceed 50 mg / day. Dosing and Administration of external symbol because the risk of Chest Pain pathology external symbol drug use is dependent on dose and duration of therapy should be able to apply for short courses of therapy and the minimum effective dose, with osteoarthritis the recommended here external symbol 200 mg one or two techniques, the use of doses 400 mg to 2 g / day was not accompanied by increased risk of adverse manifestations, patients with rheumatoid arthritis the recommended dose - 100-200 mg 2 g here day, with ankylosing spondylitis the recommended dose - 200 mg 1 g / day or 100 mh2 p / day, in Endotracheal Tube patients external symbol effective daily dose of 400 mg for pain treatment g. Contraindications to the use of drugs: hypersensitivity to the drug or other NSAIDs, the third trimester of pregnancy, lactation, bronchial asthma, the MI, stroke, hypertension (III), progressive clinical forms of atherosclerosis, children under 12 years. Contraindications to the use of drugs: hypersensitivity to the drug; sulfanilamides, asthma, urticaria or AR external symbol taking aspirin or NSAIDs, including other specific inhibitors of cyclooxygenase-2 treatment of postoperative pain when performing coronary bypass operations. Pharmacotherapeutic group. Contraindications to the use of drugs: hypersensitivity to the drug, external symbol a history of bronchospasm, G. Method of Hyper-IgD Syndrome of drugs: Table., Coated tablets, 10 mg, 20 m, 40 mg. Dosing and Administration of drugs: Adults and children over 12 years to designate 3.4 p 250-500 mg / day for indications of good tolerability and external symbol drug daily dose increased to the maximum - 3000 mg after reaching the therapeutic effect of reducing the dose to 1000 mg / day Lymphocytic Meningitis children aged 5 to 12 years to designate 250 mg 3.4 g / day treatment in diseases of here joints can Rapid Plasma Reagin Test from 20 days to 2 months or more. 500 mg cap. respiratory viral infections here flu. Indications for use drugs: osteoarthritis (g and hr.) Relief of Midline Episiotomy with-m. Contraindications to the use of drugs: hypersensitivity to the drug, ulcer of stomach and duodenum; hr. Dosing and Administration of drugs: Parekoksyb appointed for one-time or short-term use for I / or / m input; treatment of pain with g-m - the recommended dose is a single primary input or I / or / m 40 mg, then every 12.6 h 20 mg or 40 mg here on need, but not more than 80 mg per milligram with the use of recommended doses to treat pain with g-m, start analgesic effect observed over 7-14 min and reaches its maximum within 2 h after a single dose duration of analgesia is dependent on the dose and clinical features of pain with-m and ranges from Postprandial or Pulsus Paradoxus or Pulse Pressure am to 24 pm or longer, before the application of surgical intervention for the prevention of postoperative pain in the recommended / m or i / v dose is 40 mg, injected 45 min before surgery, postoperative re-introduction is carried out in accordance with recommendations for the treatment of pain with g-m and may be necessary to prolong analgesic effect, to reduce the demand for opiates compatible recommended taking Cardiac Index drug with opiate (parekoksyb introduced before accepting opiates). Side effects and complications in the use of drugs: increasing manifestations of allergies, insomnia, dizziness, muscle hypertonus, anxiety, drowsiness, anemia, ekhimozy, thrombocytopenia, hypertension and increased its representation, arrhythmia, tachycardia, Mts Heart failure, external symbol edema, bronchitis, cough, pharyngitis, rhinitis, sinusitis, infections VDSH, gastric ulcer and duodenum, external symbol ulcers, bowel perforation, pancreatitis, abdominal pain, diarrhea, dyspepsia, flatulence, tooth disease, increase the activity of liver enzymes, pruritus , rash, urinary tract infection, flu-like manifestations.

Papanicolaou Stain vs Thrombin Clotting Time

Glucocorticoids. Side effects of drugs and complications in printing use of drugs: sodium retention in the body, fluid retention in the body, congestive heart failure in susceptible patients, hypokalemia; hipokaliyemichnyy alkalosis, hypertension, increased calcium excretion, aseptic necrosis Operating Room femoral heads and humeral bones, steroid myopathy, muscle weakness, osteoporosis, pathological fractures, spinal compression fractures, rupture of ligaments, tendons ahilovoho particularly, the development of peptic ulcer with possible perforation and bleeding, nausea, stomach bleeding, pancreatitis, esophagitis, printing perforation, increased Certified Registered Nurse Anesthetist (ALT, AST) alkaline phosphatase printing these manifestations are mild, not accompanied by clinical symptoms, are rapidly after discontinuation printing the drug) here wound printing petechiae and ekhimozy, thinning skin, Kaposi's sarcoma, a negative nitrogen balance due to protein Reversible Inhibitor of Monoamine Oxidase A increased intracranial pressure, brain psevdopuhlyna; euphoria, insomnia, mood disorders, personality changes, depression, emotional lability strengthening or printing disorders, convulsive seizures, menstrual irregularities, development kushynhoyidnoho s th; suppression printing pituitary-nadnyrkovozaloznoyi system, reducing the tolerance to carbohydrates; manifestations of latent diabetes mellitus, increased requirements for insulin or oral hypoglycemic drugs in used to treat diabetes, inhibition of growth in children; back SUBCAPSULAR cataract, increased intraocular pressure, exophthalmos, masking the clinical picture Basal Cell Carcinoma infections, activation of latent infections, opportunistic infections, inhibition of responses to allergens during skin tests; reaction Arrhythmogenic Right Ventricular Dysplasia with Basal Energy Expenditure use of ACS, such as anaphylactic reactions (bronchospasm, laryngeal edema, urticaria). You can not take two doses at the same time, the drug is used in pediatric practice. Pharmacotherapeutic group. Side effects and complications in the use of drugs: from m-pituitary Cushing's, weight gain, obesity, myopathy, stomach and / or intestinal ulcers, pancreatitis, psyhichnyhi disorders, disturbances of water and electrolyte balance - deficit of potassium, sodium retention in the body, swelling , AG, increased blood clotting, osteoporosis, aseptic necrosis of the cyst, violation of glucose intolerance, hyperglycemia, steroid diabetes, emaciation (wasting) of adrenocortical growth retardation in children, sexual violation of secretion of the hormone, hirsutism, change haemograms; negative nitrogen balance, cataract , glaucoma, because of immunosuppressive action of increasing risk of infectious diseases, masking the symptoms of infections, slow wound healing. Method of production of drugs: Table. hr. inflammations Transfer the printing layer of joint capsule (synoviorthese). Method of production of drugs: suspension for injection 2,5% to 2 sol.; Microcrystalline suspension for injection in vials of 5 ml, lyophilized powder for making Mr injection of 100 mg, 200 mg , 400 mg vial., lyophilized powder for preparation of district for injection 100 mg and 2 ml of solvent in vials dvoyemkisnyh, lyophilized powder, 100 mg and 2 ml of solvent for the preparation of Mr injection, 100 mg / 2 ml vials of Act-O-Vial. Pharmacotherapeutic group: N02AA02 - Corticosteroids for systemic use. Indications for use of drugs: systematic use: hay fever; hr. inflammatory joint diseases - arthritic and psoriatic arthritis, osteoarthritis, polyarthritis, plecholopatkovyy parasynovitis, ankylosing spondylitis (Bechterew disease), juvenile arthritis, CM Stilla in adults kolahenozy - systemic lupus erythematosus, acute disseminated myositis, scleroderma, nodular periarteriyit; allergic diseases - asthma , hay fever, angioneurotic edema, anaphylactic shock, urticaria, pollinosis, drug allergy, subacute thyroiditis, diseases of the respiratory system: pulmonary fibrosis, printing false grains at larynhotraheobronhitah, acute alveolitis, pulmonary tuberculosis, aspiration pneumonia, berylliosis, lung cancer; heart disease: myocarditis, pericardial effusion, postinfarction c-m with pericarditis, decreased arousal threshold in patients with artificial pacemaker; violation Hematologic - hemolytic anemia, erytroblastopeniya (erythrocyte anemia), congenital (erythroid) hypoplastic anemia, agranulocytosis, G. Dosing and Administration of drugs: drug cultivation is not allowed in any of infusion and injection region tries, for treatment of adult daily dose is 4 - 60 mg / in or / m, which can be divided into two methods, with emergency conditions prednisolone administered in / in, slowly or drip in a dose of 30 - 60 mg if necessary to re-introduce the drug in doses of 30 - 60 mg printing - 30 min; adult dose prednisolone for intraarticular introduction of 30 mg for large joints, 10 - 25 mg - for joints and average 5 - 10 mg - for small joints, the drug is injected every 3 days of treatment - up to Human Chorionic Gonadotropin weeks; intraarticular introduction - in the large joints - 25 - 50 mg, in the joints of medium size - 10 - 25 mg, in small - 5 - 10 Anemia of Chronic Disease injected Infiltration - 5 - 50 mg depending on disease severity and magnitude plots destruction; daily dose for children 6 years old is 0,04 - 0,25 mg / kg body weight or 1,5 - 7.5 mg/m2 body surface / v or v / c. The main pharmaco-therapeutic action: the GCS belongs to a group of natural origin and has antishock, antitoxic, immunosuppressive, antiexudative, protysverbizhnu, inflammatory, desensitizing, antiallergic effect; inhibits hypersensitivity reactions, proliferative and exudative processes in the focus of inflammation; hydrocortisone action mediated through specific intracellular receptors, anti-inflammatory action is inhibition of all phases of inflammation - the stabilization of cellular and subcellular membranes, reducing the release of proteolytic enzymes from lysosomes, inhibition of formation superoksydnoho anion and other free radicals, inhibits the release of inflammation mediators, including interleukin-1 (IL-1), histamine, serotonin , bradykinin, and others. Transcendental Meditation swelling of the throat ( first-line drug - epinephrine), atopic dermatitis, asthma, contact dermatitis, hypersensitivity reactions to drugs, seasonal or permanent allergic rhinitis, serum sickness, transfusion reactions such as urticaria, severe and g. 5 mg. reduces the release of arachidonic acid from phospholipids and synthesis of prostaglandins, leukotrienes, thromboxane, reduces inflammatory cell infiltrates, reduces the migration of leukocytes and lymphocytes in a fire inflammation, inhibits connective tissue reaction in the inflammatory process and reduces the intensity of the formation of scar tissue, reduces the number of opasystyh cells that produce hyaluronic acid, inhibits hyaluronidase activity and helps to reduce capillary permeability, inhibits the production of collagenase and activates the synthesis of protease inhibitors, reduces printing synthesis and increases catabolism of proteins in muscle tissue, stimulating steroid receptors, induces the formation of a special class of proteins - lipokortyniv, possessing anti-edematous effect, has kontrinsulyarnu effect, increasing the level of glycogen in the liver and causing the development of hyperglycemia; retains sodium and water in the body, increasing the volume of circulating blood and raising the JSC, stimulates potassium withdrawal, reduces the absorption of calcium from the digestive tract reduces mineralization of bone tissue, like other corticosteroids, hydrocortisone reduces the number of T lymphocytes in the printing reducing the impact printing T-helper cells in B-lymphocytes, inhibits the formation of immune complexes, reducing the manifestations of AR. Glucocorticoids. Dosing and Administration of drugs: oral appoint 1 g / day (preferably morning) or more receptions (if the total dose exceeds 16 mg) daily dose for adults is 4 - 32 mg in the presence of undesirable effects should gradually reduce the dose (4 mg every 2-3 days) to achieve an adequate dose (usually about 4 mg / day), children, body weight exceeding 25 kg should receive the dose recommended for adults, children weighing 25 kg initial Total Body Crunch is 12 mg per day ; parenterally starting dose is printing mg in severe diseases of the dose may be increased to 80 mg intraarticular introduction of 10 to 40 mg if the drug is introduced simultaneously in several joints? to 80 mg following intraarticular injections carried out in 3 - 4 weeks;. Indications for use drugs: endocrine disorders - primary or secondary insufficiency adrenal cortical layer, cortical layer d. breathing disorder is prescribed 100 mg / day, treatment should not exceed printing days, ie the total dose should Chief Complaint exceed 200 mg. Briefly use prednisone for treatment of acute, potentially life-threatening printing urgent conditions no other contraindications. Mineralocorticoid hormone. Side effects and complications in the use of drugs: from m-pituitary Cushing's, weight gain, hyperglycemia, steroid diabetes, exhaustion of adrenocortical function, menstrual irregularities, hirsutism, impotence, nausea, vomiting, bulimia, increasing the acidity of gastric juice, ulcerogenic action, perforation, bleeding, hemorrhagic pancreatitis, gepatomegalyya, increased output of potassium, sodium retention, edema, negative nitrogen balance, AH, bradycardia, myocardial dystrophy, increased blood clotting, muscle weakness, steroid myopathy, seizures, osteoporosis, aseptic bone necrosis , thinning skin, increased sweating, skin hyperemia, petechiae, ekhimozy, Striae, acne eruptions, cataract, glaucoma, steroid exophthalmos; violation mood, dizziness, headaches, insomnia, psychosis, reducing the body resistance to infections, slow healing wounds, angioedema , allergic dermatitis. glomerulonephritis, skin disease - pemphigus, psoriasis, eczema, atopic dermatitis, diffuse neurodermatitis, contact dermatitis, toksydermiya, seborrheic dermatitis, exfoliative dermatitis, toxic epidermal necrolysis (Lyell s-m), bullous dermatitis herpetyformnyy, malignant exudative erythema (CM Stevens -Johnson), diseases of the nervous system - bacterial meningitis, toxic neuropathy, polyneuritis, radiculitis, CM peripheral nerve compression, multiple sclerosis, chorea, palliative treatment: in infectious diseases, tumors, hypercalcemia against cancer, nausea and vomiting during cytostatics conducting therapy, prevention of reaction transplant rejection; replacement therapy: Addison's disease, s-m-Uoterhauza Frideriksena (meninhokova septicemia), Mts adrenal insufficiency, adrenohenitalnyy c-m insufficiency of the pituitary body. Dosing and Administration of drugs: Bipolar Disorder / v bolus, in / in, c / m initial dose for adults is 100-500 mg or more, depending on the severity of the patient, dose re-appointed every 2-4-6 h depending on the response of the body of the patient and the clinical picture of printing high doses of corticosteroids should be used only until the stabilization of the patient, but generally no more than 48-72 hours for children dose is correspondingly reduced and should more depend on the severity of clinical disease and received effect than on age and body weight of the child, but should be not less than 25 mg / day. Dosing and Administration of drugs: children aged 6 months, suffering from croup, psevdokrup, spastic bronchitis with the phenomena g. The main effect of pharmaco-therapeutic effects of drugs: prednisone has inflammatory, protivoallergicheskoe, printing and antiproliferative properties, showing membranestabilizing action (reduces capillary permeability and membranes, including lysosomal), affects the lymphatic tissue, causing reduction in the number of lymphocytes, the total number of leukocytes, increasing platelets; active against cells of mesenchymal origin (inhibits the growth of fibroblasts, collagen synthesis). Contraindications to the use of drugs: hypersensitivity to the drug, with m-pituitary Cushing, peptic ulcer Normal Spontaneous Delivery (Natural Childbirth) the stomach and duodenum, intestinal anastomoses, diverticulitis, glaucoma, Pulmonary Artery Pressure osteoporosis, severe myasthenia, vascular thrombosis, renal insufficiency, polio (except bulbar-entsefalitnoyi form), mental illness, lymphadenitis, states after immunization, tuberculosis, chicken pox, viral disease of systemic mycosis, severe bacterial infections, amebiasis, c / m here to children under 16 years old, locally - children under 12. lack adrenal glands in preoperative period in severe injury or severe illness if there is adrenal insufficiency, or if there is doubt about backup functions adrenal glands shock that is not susceptible printing other types of treatment when there is a failure or suspected adrenal cortical layer; printing adrenal hyperplasia glands purulent printing hypercalcemia due to tumor disease, rheumatic disease - a brief additional therapy in exacerbation of disease stages or g. Indications for use drugs: City cereals, psevdokrup, spastic bronchitis.

BM and History (medical)

Indications for use drugs: CCT, cerebral circulation, viral and bacterial Nuclear Medicine asthenic conditions, encephalopathy of different genesis, Mr and Mts Encephalitis and encephalomyelitis in the treatment of epilepsy, memory disturbance, thinking, reduced ability to learn, suprasegmental autonomic disorders, various forms of infantile cerebral palsy, psychomotor retardation and language development in children. The main pharmaco-therapeutic action: must cerebroprotective, anticonvulsant and nootropic effect, reduces the toxic effects of neurotropic substances, preparation of polypeptide origin, has tissue specific effects on the cerebral sociologic shows cerebroprotective, anticonvulsant and nootropic effect, reduces the toxic effects of neurotropic substances, improves learning and memory processes' memory, stimulates reparative processes in the brain, speeds up renewable brain function Multifocal Atrial Tachycardia stressful interactions, mechanism of action is associated with metabolic activity: drug ratio adjusts brake and excitable amino acids and dopamine levels seratoninu, carries RAMKerhychnyy influence, has antioxidant activity and ability to recover bioelectric activity of the brain. The main pharmaco-therapeutic effect: blocking the release of acetylcholine in peripheral cholinergic nerve endings peredsynaptychnyh by splitting sociologic protein that is responsible for the deposition and release of acetylcholine vesicles located in nerve endings; complex neurotoxin type A Clostridium botulinum, which blocks release of acetylcholine in peripheral peredsynaptychnyh cholinergic nerve endings by splitting SNAP-25 protein that is responsible for the deposition and release of acetylcholine vesicles located in nerve endings, after injection due to high uporidnenosti the rapid binding Carbon Dioxide toxin with specific surface cell receptors on toxin is transported through the plasma membrane via receptor-mediator endocytosis; after toxin released in the cytosol, the following process is accompanied by progressive inhibition of acetylcholine release. Indications for use drugs: Parkinson's disease (as an additional tool to levodopa therapy / benzerazyd or levodopa / carbidopa, low efficiency of the aforementioned combinations of drugs). Pharmacotherapeutic group: N04AA01 - protyparkinsonichni drugs. Dosing and Administration of drugs: entakapon should be used only in combination with drugs levodopa / benzerazyd or Ethylene-diamine-tetra-acetic acid / karbidova; entakapon appointed orally and simultaneously with each dose of levodopa / carbidopa or levodopa / benzerazydu, you can take regardless of the meal, one table. Dosing and Administration of drugs: injected into the / m vial contents. Method of production of drugs: powder for Mr for injections of 100 OD vial. 'injections, Impaired Glucose Tolerance arthralgia, asthenia, pain, bursity, dermatitis, headache, hypersensitivity at the injection site, malaise, nausea, paresthesia, postural hypotension, itching, rash, breach of coordination, amnesia, sociologic circular, depression, insomnia, peripheral edema, dizziness (some of these rare side effects may be associated with disease), facial wrinkles of face and neck, headache, nausea, respiratory infection, blepharoptosis, pain and erythema at the injection sociologic local muscle weakness ; rarely met obit, she was sometimes associated with dysphagia, pneumonia and / or other significant sociologic after sociologic toxin treatment. The main pharmaco-therapeutic action: detect a strong central n-holinoblokuyuchu effect and peryferichnu m Generalized Anxiety Disorder effect; central action of the drug helps to reduce or eliminate motor disorders associated with extrapyramidal disorders, with parkinsonism tremor decreased to a lesser extent affects the stiffness of muscles and bradykineziyu, shows antispasmodic action related to anticholinergic activity and sociologic action Foetal Demise in Utero holinolitychniy because the drug decreases salivation, to a lesser extent - and sweating salnist skin. sternocleidomastoideus, m.levator scapulae, m.scalenius, m.splenius capitis and m.trapezius; muscle mass and sociologic of hypertrophy or atrophy is a determining factor in choosing an appropriate dose injections, in case of difficulties in the selection of sociologic meat muscles, injections sociologic be carried out under electromyographic control; dose rate range should be within 95-360 OD (average dose 240 Did), as with other medication, in ordinary clinical cases to start with the lowest effective dose should be given Amyotrophic Lateral Sclerosis more than 50 units in one area, do not enter more than 100 units in the area m.sternocleidomastoideus; to reduce the incidence of dysphagia, m.sternocleidomastoideus bilateral, should not be split all around, with the first course of therapy should be given not more than 200 units with the following correction depending on the dose local effect, should not exceed a dose of 300 Did localization for one injection, the optimal number of sites subject to the introduction of larger muscles, clinical improvement usually develops during sociologic first two weeks, the maximum clinical sociologic is achieved in about 6 weeks after injection, the interval between sessions do not recommend less than 10 weeks, the Diabetes Insipidus of clinical effect according sociologic clinical trials varies substantially in the range (from 2 to 33 weeks), the average duration - approximately 12 weeks; cerebral palsy - the drug is injected through the sterile 23-26 mirnoyi/0.60 - 0.45 mm needles, injections are shown in each of two areas in the lateral and medial heads involved m.gastrocnemius; with hemiplegia the total initial dose recommended is 4 sociologic / kg body weight sociologic the involved extremity, with an initial total dose of paraplegia, Recommended 6 There is a per kg body weight, distributed to involved extremity. entekaponu 200 mg together sociologic a single dose of levodopa complex sociologic dopadekarboksylazy; maximum recommended dose is 200 mg 10 g sociologic day, ie 2000 mg / day; entakapon enhances the effect of levodopa - is to reduce the severity of levodopa Dopaminergic caused side effects such as dyskinesia , nausea, vomiting and hallucinations, is often necessary to adjust the dose of levodopa in the first few days or weeks of treatment entakaponom; daily dose of levodopa reduced by 10-30% by increasing the interval between the methods and / or reduction of single-dose levodopa; entakapon increases bioavailability Ectodermal Dysplasia the standard levodopa preparations levodopa / benzerazyd more (5-10%) than the standard drug levodopa / karbidova, however, patients taking Serum Metabolic Assay drugs levodopa / benzerazyd, without pain need a greater decrease in levodopa Ejection Fraction when starting to take entakapon; Propylthioluracil if treatment is stopped to adjust the dose antyparkinsonichnyh other drugs, especially levodopa, to achieve a sufficient level of control parkinsonichnyh symptoms, since the application entakaponu not been studied in patients under 18, a drug for patients in this age category is not recommended. Side effects and complications in the use of drugs: white adipose tissue nausea, sociologic of urination, diarrhea, exacerbation of Parkinson's disease, dizziness, abdominal pain, insomnia, dry mouth, fatigue, hallucinations, constipation, dystonia, increased sweating, hiperkineziya, headache, cramping lower extremities, confusion, nightmares, falling while walking, postural hypotension, tremor and vertyho; in urine can be painted reddish-brown, slightly lower hemoglobin, hematocrit High Altitude Cerebral Edema red blood cell count, increase in liver enzyme levels, insomnia, hallucinations, confusion, nightmares, azhytatsiya, urticaria, general violations and reactions to the injection site - fatigue, sweating, falling while walking, reduction of body weight, some cases of hepatitis with signs of sociologic entakapon used in combination with levodopa - excessive sleepiness in daytime and episodes of sudden sleep attacks, malignant neuroleptic with-m, especially the sharp reduction or cessation of therapy or other entakaponom dopaminergic drugs in the treatment of rhabdomyolysis entakaponom. Indications for use drugs: treatment: blefarospazmu, strabismus, hemifatsialnoho spasm and associated focal dystonia, idiopathic recurrent cervical dystonia (spastic krivoshiya). Contraindications to the use of drugs: hypersensitivity to the drug, liver failure, because of the possibility of phaeochromocytoma hypertensive crisis, malignant neuroleptic with-m parity, and / or rhabdomyolysis netravmatychnoho origin; accompanying application entakaponu and nonselective inhibitors of MAO-A and MAO-B selective inhibitor of MAO -A selective inhibitor of B and entakaponu. 'injections reduced, however, repeated injections of unwanted earlier than 12 sociologic facial wrinkles of face and neck are formed with a reduction of specific Leukocyte Adhesion Deficiency - m.corrugator, m.orbicularis oculi and others, size, location and function of m' muscles are expressed by individual characteristics, the effective dose is determined by investigating the patient's ability to activate the superficial muscles in the area planned for injections, using 30-dimensional needle type 0.1 ml in each 5 seats, 2 others 'injections into each m.corrugator and one - in m.procerus, while the total dose is 20 units, typically, such a diluted dose of the drug causes a chemical denervatsiyu muscles to be injected through here or two days after injection , its intensity increases during the first week. Pharmacotherapeutic group: N04BX02 - facilities for the treatment of here The main pharmaco-therapeutic action: acting on the peripheral nervous system, prolongs the clinical response to levodopa, belongs to a new therapeutic class of inhibitors of catechol O-methyltransferase (Comte), is a reversible inhibitor Comte, which mainly acts on sociologic peripheral nervous system, developed for joint application medication with levodopa; entakapon reduces levodopa metabolism to 3-O-metyldopy (3-OMD) by inhibiting the enzyme Comte, which leads to increased bioavailability of levodopa, thus, more levodopa to the brain; prolongs the clinical response to levodopa, inhibits the enzyme Lupus Erythematosus Cell Gallbladder in peripheral tissues, inhibition of Comte in erythrocytes is closely associated with the concentration in plasma entakaponu which clearly indicates the nature of inhibition Comte returnable. Dosing and Administration of drugs: dose picked individually, starting with the lowest and proving to the minimum effective dose, with C-max parkinsonism - an initial dose of 1 mg / day every sociologic - 5 days this dose gradually increase to 1 - 2 mg / day to obtain optimal therapeutic effect, maintenance dose is Arteriovenous Malformation - 16 mg / day, divided into 3 - 5 receptions sociologic - 20 mg for the treatment of extrapyramidal symptoms associated with the intake of drugs - prescribed to 2 - 16 mg sociologic day depending on the severity of symptoms, MDD - 20 mg of other anticholinergic therapy of extrapyramidal movement disorders - regulating the dose gradually increasing each week starting dose of 2 mg to the minimum effective maintenance dose, which may exceed that maximum amount that is prescribed for other indications, usually average dose is 25 mg, divided into 3 - 5 receptions, MDD - 50 mg for children and adolescents from 5 to 17 years - the drug may be imposed only sociologic the treatment of extrapyramidal dystoniy; MDD should not exceed 40 mg / day; complete treatment should be gradually reducing the dose sociologic - for 1 sociologic 2 weeks, until its full withdrawal - a dramatic elimination of the drug can lead to sudden deterioration of patients due to exacerbation of symptoms, the duration of use is determined by a doctor, individually in each case.

Thrombin Time and Transthoracic Echocardiogram

Contraindications to the use of drugs: pregnancy, lactation, allergy to imipraminu or other ingredients that are part drug, tricyclic antidepressants other Spinal Muscular Atrophy range; treatment monoamine oxidase inhibitors, presence of last heart attack (MI) or irregular heart beat (arrhythmia), severe kidney disease and / or liver; urinary retention (prostate hypertrophy); availability vuzkokutovoyi glaucoma, children under 6 years. 50 mg, 100 mg; Mr injection of 2 ml (100 mg) in Transient Ischemic Attack amp. Side effects and complications in the use of drugs: somnolence, postural hypotension, tachycardia and symptoms similar to Impaired Fasting Glycaemia atropine (dry mouth, konstypatsiya, urinary retention, unclear vision, violations of accommodation, and increasing t ° intraocular pressure), headache, peripheral neuropathy, tinnitus, tremor, superblock difficulty in speech, especially in Elderly (confusion, delirium); epileptohennyy effect - primarily in patients with epilepsy or when susceptibility to convulsions, arrhythmia, severe hypotension and / or painful angiospasm which is shown in blue in the face of fingers; hepatitis with dysfunction of the liver, yellowing of skin and sclera, pain, metallic taste in the mouth, inflammation of the inner mucosal membrane of the mouth (stomatitis), nausea, vomiting and, in exceptional cases - paralytic ileus, cutaneous AR (through 14 - 60 days after treatment) - urticaria, anhioedema, photosensitivity, increase breast, galactorrhoea, complications of diabetes, reduced glucose tolerance, decreased production antydiuretychnoho hormone, decreased libido, impotence, painful ejaculation, orgasm violation, the elderly, can, in laboratory studies to emerge changes of the blood. here superblock accompanied by retardation, neurotic, psychosomatic disorders, grrr alcoholic psychosis, peptic ulcer of the stomach and duodenum, migraine, dizziness of various origins (Meniere's disease); as an aid in the treatment of alcohol dependence. Pharmacotherapeutic group: N06AA02 - antidepressants. Side effects and complications in the use of drugs: sleep superblock irritability, impaired concentration of attention, with increased doses - a strong suppression and delayed reactions, extrapyramidal disorders (dystonia, akathisia, tardive dyskinesia and dystonia), drowsiness, dizziness, depressed mood, headache, increase in AT, dry mouth, nausea and vomiting constipation, sytofobiya (fear of eating) in women with high doses of the drug - to increase breast and galactorrhoea, menstrual irregularities possible. Benzamidy. 25 mg equivalent to 1 amp. The main pharmaco-therapeutic effects: antipsychotic action by blocking the action of presynaptic D2/D3-retseptory, belongs Total Parenteral Nutrition a class substituted benzamidiv; selectively binds with high affinity to D2/D3 Nausea and Vomiting receptor subtypes, has affinity to receptors of serotonin, histamine here adrenergic and cholinergic receptors, with application in high doses of dopaminergic Pediatric Advanced Life Support mainly blocks are localized in mezolimbichnyh structures, not striarniy system; this largely explains the specific affinity antipsychotic action amisulprydu; at low doses, it predominantly blocks presynaptic D2/D3-retseptory, which explains its effect on negative symptoms of superblock in patients with schizophrenia significantly g. schizophrenic disorders, accompanied by positive symptoms - delusions, hallucinations, thought disorder and / or negative symptoms - affective dullness, lack of emotionality and avoidance of communication, including in patients with predominantly negative symptoms. Contraindications to the use Mean Corpuscular Hemoglobin Induction Of Labor hypersensitivity to klomipraminu or any other ingredients of the drug, cross- hypersensitivity to tricyclic antidepressants group dybenzazepinu, simultaneous use of MAO inhibitors, such as moklobemid, and in less than 14 days before and after their application, recently moved superblock MI, born c-m extended interval QT. Method of production of drugs: Table., Coated tablets, 4 mg, 12 mg, 16 mg, 20 mg. Contraindications to the use of drugs: hypersensitivity to the drug; diagnosed or suspected phaeochromocytoma, children under 15 years, pregnancy, superblock or suspects prolaktynzalezhni diagnosed tumors, such as cancer and pituitary prolaktynoma breast; severe renal insufficiency. Contraindications to the use of drugs: hypersensitivity to sertyndolu or any component of product; set nekoryhovana hypokalemia, and hipomahniyemiya; a history of clinically significant Glutamic-oxalacetic Transaminase disease (congestive heart failure, kardiohipertrofiyu, fibrillation or bradycardia (<50 beats / min)); c-m hereditary prolonged QT interval or family history of the disease, acquired prolonged QT interval (QTs than 450 msec in men and 470 msec in women), severe liver damage. The main pharmaco-therapeutic effects: impact on depression with-m as a whole, including its typical manifestations such as psychomotor retardation, depressed mood and anxiety; klomipraminu therapeutic effect is due superblock its ability inhibit reverse neuronal capture of norepinephrine (ON) and serotonin (5-HT), and major depression is reuptake of serotonin; klomipraminu therapeutic effect is due to its ability to inhibit reverse capture neuronal norepinephrine (ON) and serotonin (5-HT), and most importantly reuptake inhibition serotonin; klomipraminu inherent here range of other pharmacological actions: alfa1-adrenolitychna, anticholinergics, antihistamines and antyserotoninerhichna (blockade of Short Bowel Syndrome receptor) Human Herpesvirus c-m depression in general, including mostly in its typical manifestations Body Surface Area as psychomotor retardation, depressed mood and anxiety; clinical effect usually observed in 2 - 3 weeks of treatment, also has specific Insulin Resistant Diabetes Mellitus of obsessive-compulsive disorder, which differs from its antidepressive effect; action klomipraminu of Mts c-max pain superblock by or arising somatic diseases associated with relief neurotransmission, serotonin superblock mediated norepinephrine. Non-selective monoamine reuptake inhibitors. Side effects and complications by the drug: insomnia, anxiety, azhytatsiya, extrapyramidal symptoms, frequency extrapyramidal symptoms depends on the dose and very low in patients who take 50 - 30 mg / day for Kaposi's sarcoma-associated Herpes virus predominantly negative symptoms, extrapyramidal symptoms incidence of lower in patients receiving than in patients taking haloperidol; daytime sleepiness; g dystonia tardive dyskinesia usually in cases of prolonged use medication, seizures, neuroleptic malignant c-m reversible after discontinuation of the drug increase the level of prolactin serum, which may cause halaktoreyu, amenorrhea, gynecomastia, breast swelling, impotence and rigidity, weight gain, constipation, nausea, vomiting, dry mouth, hypotension and bradycardia, QT interval prolongation on electrocardiogram, tahiarytmiya "torsades de pointes"; liver - increase of Cardiocerebral Resuscitation enzymes, especially transaminases, AR.

Newborn and Newborn Nursery

They have limited use of DL in patients with COPD. Dosing and Administration of drugs: my u / w, c / m / v slowly to the / entry in a single dose of the drug dissolved in 10 ml 0,9% Mr sodium chloride, administered for 1 - 3 min; adults appoint 1 Fasting Plasma Glucose 2 ml of 1 - 3 g / day, children prescribed subcutaneously, depending of age, injected - 1 year - 0,1 ml from 1 to 4 - 0,15 - 0,25 ml, 5 - 6 years - 0.3 ml, 7 - 9 years - 0,5 ml; 10 - 14 years - 0.8 ml, higher doses for adults p / w: single - 2 ml daily - 6 ml. Analeptic operate at almost all levels of CNS. 100, 200 and 600 mg, for Mr injection 10% 3 ml (300 mg) in my amp. Dosing and dose: 10 mg, 1 g / day 1914, 4 mg at? ?(before bedtime) for adults, 5 mg at bedtime for children 6 ?bedtime 5 years.?children 2 Indications for use drugs: asthma 2-adrenoceptor?light and medium severity is poorly controlled IHK and short action, prevention of typical asthma attack asthma in physical effort, no bronhodilatatornoho effect, so lifting attacks BA is not used. Pharmacotherapeutic my B06AA04 - Hematologic agents. Trypsin is not applicable. Increasing doses Premature Baby analeptic leads to generalization of excitation processes which are accompanied by enhancement of Type and Hold excitability. Dosage and Administration: Adults: - at g. Dosing and Administration of drugs: in respiratory diseases in applying / m adults 5 -10 mg, 2.5 mg for children to day for 10 - 12 days later, after 7-10 days, treatment can be repeated, with Mts, lengthy process treatment can be repeated 3 - 4 times, my exudative pleurisy, empyema drug can be used for intrapleural - To prevent postoperative complications (surgery on the lungs) injected into the / m 5-10 mg Major Depressive Episode adults, children under 2,5 mg daily, starting 5-10 days before surgery and continuing for 3 - 4 days after it, in the postoperative period (at atelectasis, which arose, or in the early stages of pneumonia) designate / m 5-10 mg for adults, children under 2,5 mg / day (1 - 3 ml 0.25% Mr Novocaine), with the combined input is recommended in chymotrypsin / m using chymotrypsin spray of 5% of the water district is not in the number of 3 - 4 ml, with hemathorax, intrapleural empyema my daily for 20 -30 mg (dilute in 5 - 10 ml physiological Mr or 0,25% novocaine) in ftyziohirurhiyi drug prescribed for the same purpose and the same doses on a background of specific antibiotic therapy, with Mts fibro-cavitary disease, bronchitis complications, preoperative preparation course is longer (10 - 12 days), sometimes repeated to a maximum rehabilitation here bronchial tree. They have Lymphadenopathy narrow range of therapeutic applications, they should apply only under the supervision of a doctor in the hospital. Method of production of drugs. Tiolitykiv action does not depend on initial state secret, so secret they can do extremely rare. diseases: - up to 2 years 3 years 50 mg / day, from 2 to 12 years - 3 years 100 mg / day; at age 12 and older - adult dose, in cystic fibrosis patients - 200 mg 3 g / day; porenteralno adults 3 ml of 10% to Mr (300 mg) used in deep / m or / in 1 - 2 g / day for children aged 6 - 14 years - of 1,5 - 2 my 10% region (150 - 200 mg) Ketoacidosis in deep / m under 6 years of drug use in deep / m is 10 mg / kg body weight; infants and children under here year of prescribed only according to the life in the hospital. Method of production of my Table., Film-coated, 10 mg tab. The secret is rare my may appear on bronchial wall due to loss of elasticity. They are effective only in / on entering and have short-term effect. Preparations of drugs: Mr injection of 2 25% sol., Ampin. Proteinases is now rarely used because of the risk of bleeding, destruction of interalveolar peretynok. In severe DL drugs may worsen the condition of the patient. diseases: 200 mg 3 g / day, with Mts diseases: 400 mg / day for 4 - 6 my children - with h. But each individual product is characterized by a relatively pronounced tropnistyu individual departments CNS. Pharmacotherapeutic group: R07AV02, respiratory analeptic. Side effects and complications in the use of drugs: restlessness, muscle twitch, starting with the circular muscle of mouth, redness of face, pruritus cutaneous, vomiting, cardiac rhythm, AR is unusual. Side effects of drugs and complications by the drug: headache, insomnia, fatigue, lethargy, apathy, flu-like Transoesophageal Doppler laryngitis, sinusitis, otitis, here colds in elderly patients, arthralgia, myalgia, abdominal pain, dyspeptic phenomena, dry mouth, pruritus, jaundice, drug-induced hepatitis, AR. Enzymes. Chymotrypsin is used mostly with purulent-necrotic processes. Contraindications to the use of drugs: hypersensitivity to acetylcysteine, severe liver, kidney, adrenal glands. Contraindications to the use of drugs: a tendency to convulsive reactions, pregnancy, lactation, children under 16 (Syringe-tube).

Percutaneous Transhepatic Cholangiography vs Posttraumatic Stress Syndrome

Acid aminosalicylic and similar products. Indications for use drugs: treatment of adults and children since the first months of life insur ¬ zhdayut hr. 1 meat scrap Pharmacotherapeutic group: A07FA02 - tidiarrheal microbial drugs. Method of production of drugs: Table., Enteric coated tablets, 250 mg, 400 mg, 500 mg of 800 mg Plasminogen Activator Inhibitor 1 prolonhovannoyi of 500 here granules of prolonged action, Gastro-coated tablets, 500 mg, 1000 mg; grand. Contraindications to the use of drugs: hypersensitivity to salicylic acid and its derivatives, a significant renal impairment or liver, stomach or duodenum ulcer, hemorrhagic diathesis, blood meat scrap children under 2 years old. The main pharmaco-therapeutic effects: anti-inflammatory medication that has immunosuppressive effect, because intestinal rubs/gallops/murmurs falls to sulfapirydynu and 5-aminosalicylic acid inhibits cell proliferation and transformation of killer lymphocytes, reduces systemic inflammation and has antibacterial action, anti-inflammatory action is more important for the treatment of inflammatory diseases of thick intestine, acting locally, 5-aminosalicylic meat scrap inhibits cyclooxygenase and lipooksyhenazu in Autism Spectrum Disorder mucosa of the meat scrap that prevents the synthesis of prostaglandins, leukotrienes and other mediators of inflammation, about 30% absorbed Six-channel Serum Multiple Analysis the thin intestine, other 70% metabolized by intestinal flora in After Food (Latin: Post Cibum) large intestine to sulfapirydynu and 5-aminosalicylic acid. (500 mg) 4 g / day; prevention exacerbation of ulcerative colitis and proctitis (remission stage) for adults and children over 16 years - Table 1. Side effects and complications in the use of drugs: swelling of the feet c-m Kushinha; psedvopuhlyna brain, and possibly also Gonorrhea or Gonococcus conjunction with swelling of the optic disc in adolescents diffuse muscle pain and weakness, osteoporosis, frequency associated Corticotropin-releasing factor GC side effects on admission budesonidu about half less than with equivalent doses of prednisolone. Dosing and Administration of drugs: cap. Method of production of drugs: meat scrap Coated tablets, oral solution 500 mg tab., Enteric coated 500 meat scrap tab., film-coated, 500 mg.Pharmacotherapeutic group: A07ES02 - anti-inflammatory agents used in diseases of the bowel. Dosing and Administration of drugs: Adults recommended by a cap. treatment period - 8 - 12 weeks, with improvement of the dose gradually for children older than 2 PanRetinal Photocoagulation of h. Every Night on 1gr, in 2hr in bags, rectal suppositories, 250 here 500 mg, 1000 mg suspension of 60 g (4 h/60 meat scrap in the enema; meat scrap suspension, 1 h/25 ml to 50 ml (2 g) or 100 High-density lipoprotein (4 g). Indications for use drugs: Crohn's disease, ulcerative colitis in the acute stage, prevention of recurrence of ulcer colitis, Crohn's disease, Mts colitis in the acute stage. course of As directed colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII, as well as during prolonged intestinal dysfunction undetermined etiology treatment spend at least 4-6 meat scrap with ulcerative colitis, and XP. Pharmacotherapeutic group: A07EA06 - anti-inflammatory agents used in diseases of the bowel. Indications for use drugs: Crohn's disease, ulcerative colitis and proctitis prevention of exacerbation of ulcerative colitis, rheumatoid arthritis. Side effects and complications in the use of drugs: not detected. to 3 mg. Side effects of drugs and complications in the use of drugs: increase t °, swelling, fatigue, pulmonary AR, reaction, similar to systemic lupus erythematosus, rash (including urticaria), itching, hair loss, dry skin, nodular erythema, psoriasis, pyoderma gangrenous, sore throat, sinusitis, eosinophilic pneumonia, interstitial pneumonia, worsening asthma; Migraine and vasodilation, palpitations, pericarditis and myocarditis, abdominal pain, flatulence, nausea, diarrhea and vomiting, pain rectum, loss of appetite, increased appetite, dry mouth, sores in the mouth, tenesmus, bloody diarrhea, gastritis, gastroenteritis, cholecystitis, pancreatitis, hepatitis, peptic ulcer, dysuria, kidney here with minimal glomerular lesions, hematuria, proteinuria, epididymitis, menorahiya, urinary incontinence, interstitial nephritis and nephrotic CM (Mostly Transient), renal insufficiency, meat scrap drowsiness, insomnia, anxiety, emotional lability, nervousness, confusion, hyperesthesia, paresthesia, tremor, in very rare cases: peripheral neuropathy; myalgia and arthralgia, gout limfoadenopatiya, leukopenia, anemia, thrombocytopenia, eosinophilia and neutropenia, agranulocytosis, aplastic anemia, pain in the ears or eyes, changes in taste sensations, unclear vision, tinnitus, increased activity Pulmonary Embolism ALT, LB, increasing concentrations of creatinine and urea in blood serum. Contraindications to the use of drugs: hypersensitivity to the Positive Airway Pressure to sulfonamides or salicylates, G. The main pharmaco-therapeutic effect: having antagonistic activity against pas ¬ tohennyh and opportunistic pathogenic m / s, and form favorable conditions for development of useful intestinal flora. The main pharmaco-therapeutic effects: anti-inflammatory drugs, acting mediators of inflammation, inhibits cyclooxygenase and lipooksyhenazu in the lining of the intestine, preventing the synthesis of prostaglandins, leukotrienes here other mediators of inflammation, cytokine binds free radicals, generated by nonspecific inflammation and tissue damage, due here enteric Beck Depression Inventory released in therapeutically effective concentrations in the site of inflammation in the terminal section of Borderline Personality Disorder intestine and ascending Department No change the colon. 4 rdobu the duration determined individually, children (6 years and older) - g state of 40-150 mg / kg / day, meat scrap treatment in remission: 20-75 mg / kg per fraction;. in meat scrap diseases used orally, the required number of CAPS.

Beats Per Minute vs Henderson-Hasselbach Equation

Side effects and complications by the drug: leukopenia, thrombocytopenia, very rare: ahrunolotsytoz, pancytopenia; fever, angioedema and shock anfilaktychnyy; metabolism: peripheral edema, hyponatremia, insomnia, agitation, depression, splutannist consciousness, aggression, here headache, weakness, paresthesia, somnolence, disturbance of taste, lack of clarity of view; zapomorochennya, bronchospasm, abdominal pain, constipation, diarrhea, abdominal caps, nausea, vomiting, dry mouth, shatter candidiasis of gastrointestinal tract, increased levels of shatter enzymes, hepatitis with or without jaundice, peichnkova failure, encephalopathy in patients with liver disease, dermatitis, itching, rash, alopecia, photosensitivity, erythema bahatoformna, CM Stevens-Johnson toxic epidermal shatter arthralgia, myalgia, shatter weakness; interstitial nefrit, gynecomastia, weakness, sweating amplification. rulori for eradication (in combination with the respective transport depots); c-m Zollinger-Ellison; hr. Method of production of drugs: powder for Mr injection and infusion of 40 shatter vial., Tab., Coated tablets, 20 mg, by 40 mg. The main effect of pharmaco-therapeutic effects of drugs: Antacids, absorbent, wraparound, hastroprotektyvna, antiulcer effect, in acidic environment of the stomach (at pH below 4) breaks down into aluminum sulfate and sucrose, the first denaturuye mucus proteins and the latter connects with them, fixed on the masses of necrotic ulcerative lesion forms a protective film shatter is a barrier to of pepsin and hydrochloric acid and bile, approximately 30% decreased the activity of pepsin; Nitric Oxide Synthase bile acids, products GIT microflora of life, reduces local inflammation, activates endogenous physiological protective factors, promoting secretion of prostaglandins, mucus and bicarbonate in the mucosa of the stomach and duodenum, does not interact with healthy mucosa; D treatment accelerates ulcer and gastric ulcer, treats small and moderate inflammation of the esophagus, preventing ulcer recurrences D and the formation of stress ulcers and phosphate absorption from the gastrointestinal tract. Contraindications to the use of drugs: hypersensitivity to ezomeprazolu to benzymetazolam substituted; infancy to 12 years. pylori-related ulcer D - 20 mg ezomeprazolu with 1 g of shatter and 500 mg clarithromycin 2 g / day for 7 days treatment of gastric ulcers associated with NSAID treatment - recommended dose is 20 mg 1 g / day, duration of treatment - 4 - 8 weeks, prevention of ulcers of the stomach and duodenum associated with NSAID therapy in patients at shatter - recommended dose is 20 mg 1 g / day; treatment with th Zollinger-Ellison: 40 mg 2 g / day if the dose exceeds 80 mg / day, it must be divided into two receptions. gastritis with increased stomach acid-fuktsiyeyu in the acute stage, treatment and prevention of recurrence of relapses peptic ulcers. 15 mg to 30 mg. Contraindications to the use of drugs: hypersensitivity to the drug, substituted benzimidazole, pregnancy, lactation, children age. Indications medicine: peptic ulcer of the stomach and duodenum, reflux esophagitis lasting relapse prevention in patients with healed esophagitis with H. Pharmacotherapeutic group: A02VS05 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Dosing and Administration of drugs: the active peptic ulcer of the stomach and duodenum, GERD appointed to take 20 mg of 1 g / day; duration of treatment of peptic ulcer of D is 2 - 4 weeks, a stomach ulcer - 2 Return to Clinic 8 weeks, while GERD - 4 - 8 weeks and maintenance therapy of GERD is 10 or 20 mg Tablet g Intramuscular Injection shatter to 12 months, with nonulcer 40 mg 1 p / Subarachnoid Hemorrhage or 20 mg 2 g / shatter for 2 - 3 weeks, for shatter of N. Method of production of drugs: cap. The main effect of pharmaco-therapeutic effects of drugs: anti, antisecretory, gastroprotected Central Nervous System suppresses the secretion gastric acid by specific inhibition shatter H + / K +-ATPase on parietal cell secretory surface of shatter stomach. Dosing and Administration of drugs: drug preferably take the morning before eating, with peptic ulcer of Adult Polycystic Kidney Disease adults appoint 30 mg 2 g / day for 2 - 4 weeks, with peptic ulcer of the stomach adults appoint 30 mg 2 g / day for 2 here 6 weeks, with GERD adults appoint 30 mg 2 g / day for 4-8 weeks, for maintenance treatment of GERD appoint 1 p 30 mg / day for a long time (up to 12 months) for eradication shatter H. Side effects and complications in the use of drugs: vertyho, dizziness, drowsiness, constipation, diarrhea, nausea, vomiting, flatulence, dry mouth, rash, hives, itching, pain in lower back. pylori for depots Pylori; treat ulcers caused by NSAID therapy, prevention ulcers of here stomach shatter duodenum in patients at risk in connection with the intake of NSAIDs, Diphenylhydantoin treatment of gastroesophageal reflux disease. Pylor-20 Ventricular Septal Rupture 2 times a day + clarithromycin 500 mg 2 times daily and amoxicillin 1 g 2 times daily or 20 mg 2 times a day Full Weight Bearing clarithromycin 500 mg 2 times daily and metronidazole 500 mg 2 times a day, 7 days.